Blood tests during isotretinoin usually monitor liver enzymes and blood fats, especially triglycerides. A baseline panel gives your prescriber a comparison point. Follow-up testing checks whether either has risen enough to change the treatment plan. Pregnancy testing is a separate safety requirement and may use urine, not blood. Routine full blood counts usually aren't needed in otherwise healthy patients.
Accutane is a familiar brand name for oral isotretinoin. It is a prescription acne treatment that needs clinician supervision. Tests support that supervision, but a flagged number doesn't diagnose liver damage or make a treatment decision by itself.
What is usually monitored
The 2024 American Academy of Dermatology guideline, led by Rachel Reynolds, says clinicians should consider liver-function and lipid monitoring. It says routine complete blood count monitoring isn't needed in healthy patients.
| Test | What it checks | Why it matters | Main limit |
|---|---|---|---|
| ALT and AST | Enzymes that can rise when liver cells are irritated | A trend may prompt a repeat test and a review of other causes | One mild rise does not prove liver injury or identify its cause |
| Triglycerides | A type of fat in the blood | Large rises matter because severe hypertriglyceridaemia can raise pancreatitis risk | A non-fasting sample and recent alcohol can affect interpretation |
| Full lipid panel | Usually triglycerides, total cholesterol, HDL and LDL | Some labels and clinics request the full panel | Expert consensus places most emphasis on triglycerides |
| Pregnancy test | Whether pregnancy is present | Isotretinoin can cause severe fetal harm and is contraindicated in pregnancy | This may be a urine test and follows separate national rules |
| Complete blood count | Red cells, white cells and platelets | It may be ordered for a specific history, symptom or local protocol | Routine testing adds little for most healthy patients |
“Liver-function test” is common shorthand, but ALT and AST are enzymes rather than a complete measure of liver function. Your panel may include other markers because laboratories package tests together.
Eric Xia and colleagues ran a four-round Delphi study with 22 acne experts from five continents. Their 2022 JAMA Dermatology consensus supported checking ALT and triglycerides before treatment and again at the highest dose. The group opposed monthly testing and routine blood counts for otherwise healthy patients. This was expert consensus, not a trial comparing schedules.
Serious abnormalities are uncommon, but timing matters
Shirin Emtenani and colleagues compared 79,012 isotretinoin starters with 79,012 matched oral-antibiotic users. In their 2024 International Journal of Dermatology cohort, grade 3 or worse triglyceride elevations occurred in 0.4% of isotretinoin users. Grade 3 or worse AST elevations occurred in 0.2%. Most abnormalities appeared during the first three months.
Those are absolute risks of about four and two people per 1,000. The matched observational design reduces some differences between groups, but it cannot prove that isotretinoin caused each result. It also doesn't tell your prescriber what is safe for you.
This evidence explains why monthly panels aren't automatic everywhere. It doesn't mean testing has no value. Baseline abnormalities, liver disease, diabetes, obesity, lipid disorders, higher alcohol intake, family history and interacting medicines can justify closer monitoring.
How often are blood tests needed?
There is no single worldwide schedule. The current US prescribing information requires fasting lipids and liver tests before treatment. It then calls for periodic follow-up until the response is known. The label says the lipid response is usually clear within four weeks, but it does not set one monthly schedule for everyone.
UK product information uses a more fixed pattern. It calls for fasting lipids and liver enzymes before treatment, after one month, then every three months. More frequent testing may be used when clinically indicated. Local clinics can adapt the plan to your results and health history.
A 2026 JAMA Dermatology Viewpoint by Joseph Pierson and colleagues argued for even less routine testing in low-risk patients. A Viewpoint is expert argument, not a binding guideline. Current labels and local protocols still control what your prescriber must do.
Follow the preparation instructions on your request form. The US label specifies fasting lipid tests and waiting 36 hours after alcohol. If your sample wasn't fasting, tell the clinic rather than trying to interpret the result yourself. Don't skip or change a prescribed dose because of a portal flag.
How to read an abnormal result without overreacting
| What you see | What it may mean | Likely clinical next step | What it does not prove |
|---|---|---|---|
| A small isolated ALT or AST rise | A temporary change, laboratory variation or another cause | Compare with baseline, review symptoms and medicines, then repeat if needed | That your liver is failing |
| Triglycerides above the laboratory range | A treatment-related rise or another metabolic factor | Check sampling conditions, assess the size of the rise and decide whether to repeat | That pancreatitis is present |
| Repeated or marked change | A result more likely to need action | Your prescriber may investigate other causes and revise the treatment plan | Which action is right without clinical context |
| Normal results with new symptoms | A problem these panels do not measure | Report the symptom promptly instead of waiting for the next blood draw | That every isotretinoin risk has been excluded |
Reference ranges differ between laboratories. Trends, symptoms and your starting values matter more than a red colour in an app. Ask the prescriber what threshold they use and whether the result needs confirmation.
Pregnancy tests follow separate rules
Pregnancy prevention is not optional when pregnancy is possible. For patients who can become pregnant, the US label requires tests before treatment and before each prescription. It also requires testing at the end of treatment and one month later. As of October 28, 2026, FDA says pre-treatment tests must occur in a medical setting. It allows prescriber-approved home testing during and after treatment under enforcement discretion. Formal iPLEDGE changes are scheduled for November 15, 2026.
UK rules differ. The British Association of Dermatologists' 2026 guidance varies follow-up testing by pregnancy risk and contraception. Some patients need testing at each visit or every 30 days. Others may not need a mandatory monthly test. Your clinic should explain which group applies and document the plan.
Do not donate blood during treatment or for one month after the last dose. Donated blood could be given to someone who is pregnant.
Blood tests do not monitor every important risk
The current US label lists dry lips, dry skin and dry eyes among the common effects. These are tracked through symptoms, not a blood panel. Ask your treatment team about suitable moisturiser, lip care and eye care if dryness becomes hard to manage.
Mood and sexual-function changes do not appear on a lipid or liver panel. The UK MHRA's 2026 measures require assessment before treatment and monitoring at follow-up visits. Report a new or worsening concern promptly, even when every blood result is normal.
Seek urgent medical advice for a severe headache with nausea or vision changes, severe upper abdominal pain, yellow skin or eyes, or dark urine. These can signal problems that should not wait for the next scheduled test. The guide to common and urgent isotretinoin side effects explains the symptom-based warnings in more detail.
Your prescriber also needs a complete list of medicines and supplements. Current US and UK product information warns against combining isotretinoin with vitamin A supplements or tetracycline antibiotics. The tetracycline combination is linked to raised pressure around the brain. Ask before adding an acne medicine, multivitamin or supplement.
Questions to take to your appointment
- Which tests are you ordering, and what decision will each result change?
- Do I need to fast, and are there other preparation instructions?
- When is my next test after starting treatment or changing dose?
- Which result would trigger a repeat test rather than an immediate plan change?
- Which pregnancy-testing rules apply to me in this country?
- Who should I contact between appointments if symptoms appear?
Testing is only one part of the course. For changes in dryness, breakouts and timing, see the month-by-month isotretinoin guide.
Oscar Nascimento
Автор редакции, GlowUp Face
Оскар пишет о доказательном уходе за кожей, здоровье, луксмаксинге и социальных и экономических исследованиях внешности.
Профиль и все материалы →
